MAM
Mastrapasqua Asset Management Portfolio holdings
AUM
$853M
This Quarter Return
+2.01%
1 Year Return
+37.36%
3 Year Return
+54.92%
5 Year Return
+127.75%
10 Year Return
–
AUM
$377M
AUM Growth
–
Cap. Flow
+$377M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
23.46%
Holding
148
New
148
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Starbucks
SBUX
|
$10.9M |
| 2 |
Apple
AAPL
|
$9.83M |
| 3 |
Microsoft
MSFT
|
$9.82M |
| 4 |
Visa
V
|
$9.55M |
| 5 |
Home Depot
HD
|
$8.51M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 18.97% |
| 2 | Healthcare | 16.9% |
| 3 | Industrials | 14.22% |
| 4 | Consumer Discretionary | 13.5% |
| 5 | Financials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
COV
26
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $5.5M | 1.46% |
+87,575
| New | +$5.5M |
|
27
Comcast
CMCSA
$125B
| $5.48M | 1.45% |
+131,200
| New | +$5.48M |
|
28
Qualcomm
QCOM
$173B
| $5.42M | 1.44% |
+88,727
| New | +$5.42M |
|
29
3M
MMM
$82.8B
| $5.28M | 1.4% |
+48,287
| New | +$5.28M |
|
30
Abbott
ABT
$231B
| $5.24M | 1.39% |
+150,265
| New | +$5.24M |
|
31
Novartis
NVS
$245B
| $5.19M | 1.38% |
+73,381
| New | +$5.19M |
|
|
DD
32
DELISTED
Du Pont De Nemours E I
DD
| $5.13M | 1.36% |
+97,768
| New | +$5.13M |
|
33
IBM
IBM
$227B
| $5.07M | 1.34% |
+26,502
| New | +$5.07M |
|
|
ESV
34
DELISTED
Ensco Rowan plc
ESV
| $5M | 1.33% |
+86,002
| New | +$5M |
|
35
Chevron
CVX
$324B
| $4.99M | 1.32% |
+42,134
| New | +$4.99M |
|
36
McDonald's
MCD
$224B
| $4.74M | 1.26% |
+47,900
| New | +$4.74M |
|
37
Baxter International
BAX
$12.7B
| $4.49M | 1.19% |
+64,749
| New | +$4.49M |
|
38
KLA
KLAC
$115B
| $4.45M | 1.18% |
+79,785
| New | +$4.45M |
|
39
Union Pacific
UNP
$133B
| $4.44M | 1.18% |
+28,793
| New | +$4.44M |
|
|
APC
40
DELISTED
Anadarko Petroleum
APC
| $4.19M | 1.11% |
+48,737
| New | +$4.19M |
|
41
Thermo Fisher Scientific
TMO
$186B
| $4.15M | 1.1% |
+49,031
| New | +$4.15M |
|
42
T Rowe Price
TROW
$23.6B
| $4.07M | 1.08% |
+55,638
| New | +$4.07M |
|
43
Accenture
ACN
$162B
| $4.05M | 1.07% |
+56,238
| New | +$4.05M |
|
44
Northern Trust
NTRS
$25B
| $3.97M | 1.05% |
+68,524
| New | +$3.97M |
|
45
Exxon Mobil
XOM
$487B
| $3.96M | 1.05% |
+43,853
| New | +$3.96M |
|
46
Marsh & McLennan
MMC
$101B
| $3.73M | 0.99% |
+93,452
| New | +$3.73M |
|
47
Fluor
FLR
$6.63B
| $3.61M | 0.96% |
+60,790
| New | +$3.61M |
|
48
AbbVie
ABBV
$372B
| $3.18M | 0.84% |
+76,859
| New | +$3.18M |
|
49
Gilead Sciences
GILD
$140B
| $2.96M | 0.79% |
+57,796
| New | +$2.96M |
|
|
AGN
50
DELISTED
Allergan plc
AGN
| $2.59M | 0.69% |
+20,502
| New | +$2.59M |
|